Because they’re losing cash rapidly. Operating losses of $229 million result in a -41% operating margin. They burned $103 ...

Zai Lab shows strong growth in oncology/autoimmune drugs; reduced losses and efficient operations evident in Q3 results. Healthy financial status with a strong current ratio of 7.68; reduced R&D ...

Both companies are attacking massive addressable markets with differentiated products, but one has a clearer path to sustained hypergrowth. Wall Street's obsession with artificial intelligence (AI) ...

Quick Read Rocket Lab (RKLB) stock rose 174% in 2025 and completed a record 21 Electron missions. Rocket Lab’s Neutron rocket ...

A new podcast from LOCALiQ and the USA TODAY NETWORK was released today targeted towards business owners and leaders. The Growth Lab podcast explores topics in the areas of business and leadership, ...

Rocket Lab (RKLB) has quietly turned into one of the market's stronger space names this year, with the stock up around 55% over the past month and 165% over the past year. See our latest analysis for ...

As we look ahead to 2025, a number of factors poise the clinical laboratory market for continued transformation. The post-COVID-19 landscape is reshaping the industry, presenting both challenges and ...

Rocket Lab Corporation's stock rally is justified by government contracts, global expansion, and tech growth. Click here to read an analysis of RKLB stock now.

Wall Street loves a good David versus Goliath story. But what happens when two Davids are battling entirely different giants? Rocket Lab reported $123 million in first-quarter 2025 revenue, reflecting ...